{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:40Z","timestamp":1781927560995,"version":"3.54.5"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7645-26","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:10:16Z","timestamp":1781734216000},"source":"Crossref","is-referenced-by-count":0,"title":["MetALD as a Single Clinical Entity Regarding Liver Fibrosis: Comparative Assessment of MASLD-Predominant and ALD-Predominant MetALD Using Shear Wave Elastography and Non-Imaging NILDAs"],"prefix":"10.2169","author":[{"given":"Masahito","family":"Nakano","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Tokushige","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Nakano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Amano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79: 1542-1556, 2023.","DOI":"10.1097\/HEP.0000000000000696"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Feng Q, Manousou P, Izzi-Engbeaya CN, Loomba R, Thursz M, Woodward M. Unveiling the Burden of Steatotic Liver Disease: Mortality Risks by Subtype and Fibrosis Stage in a Nationwide Cohort. Liver Int 46: e70485, 2026.","DOI":"10.1111\/liv.70485"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kamada Y, Fujii H, Suzuki Y, et al. Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup Participants. Gastro Hep Adv 3: 1148-1156, 2024.","DOI":"10.1016\/j.gastha.2024.08.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tamaki N, Kimura T, Wakabayashi SI, et al. Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortality. Aliment Pharmacol Ther 60: 61-69, 2024.","DOI":"10.1111\/apt.18015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ochoa-Allemant P, Marrero JA, Serper M. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States. Hepatol Commun 7: 2023.","DOI":"10.1097\/HC9.0000000000000324"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Duarte-Rojo A, Taouli B, Leung DH, et al. Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology 81: 725-748, 2025.","DOI":"10.1097\/HEP.0000000000000852"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schambeck JPL, Forte GC, Goncalves LM, et al. Diagnostic accuracy of magnetic resonance elastography and point-shear wave elastography for significant hepatic fibrosis screening: Systematic review and meta-analysis. PLoS One 18: e0271572, 2023.","DOI":"10.1371\/journal.pone.0271572"},{"key":"8","unstructured":"8. Selvaraj EA, Mozes FE, Jayaswal ANA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol 75: 770-785, 2021."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology 66: 1486-1501, 2017.","DOI":"10.1002\/hep.29302"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. van Kleef LA, Francque SM, Prieto-Ortiz JE, et al. Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction. Gastroenterology 167: 357-367 e359, 2024.","DOI":"10.1053\/j.gastro.2024.03.017"},{"key":"11","unstructured":"11. Serra-Burriel M, Juanola A, Serra-Burriel F, et al. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study. Lancet 402: 988-996, 2023."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tavaglione F, Jamialahmadi O, De Vincentis A, et al. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol 21: 1523-1532 e1521, 2023.","DOI":"10.1016\/j.cgh.2022.03.044"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pustjens J, van Kleef LA, Younossi ZM, et al. Young Adults Are at Highest Risk of Liver Fibrosis and Mortality Associated With Steatotic Liver Disease With Metabolic Dysfunction and Alcohol Consumption. Hepatol Res 2025.","DOI":"10.1111\/hepr.70067"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Torp N, Israelsen M, Johansen S, et al. MetALD: Diagnosis and Prognosis With Non-Invasive Tests. Aliment Pharmacol Ther 62: 990-1002, 2025.","DOI":"10.1111\/apt.70281"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Park H, Cheuk-Fung Yip T, Yoon EL, et al. Impact of cardiometabolic risk factors on hepatic fibrosis and clinical outcomes in MASLD: A population-based multi-cohort study. JHEP Rep 7: 101388, 2025.","DOI":"10.1016\/j.jhepr.2025.101388"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Oh JH, Ahn SB, Cho S, Nah EH, Yoon EL, Jun DW. Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort. J Hepatol 81: 772-780, 2024.","DOI":"10.1016\/j.jhep.2024.05.042"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nakano M, Kawaguchi M, Kawaguchi T, Yoshiji H. Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U\/L, exercise habits, and metabolic dysfunction-associated steatotic liver disease. Hepatol Res 54: 655-666, 2024.","DOI":"10.1111\/hepr.14020"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall Med 38: e16-e47, 2017.","DOI":"10.1055\/s-0043-103952"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Castera L, Rinella ME, Tsochatzis EA. Noninvasive Assessment of Liver Fibrosis. N Engl J Med 393: 1715-1729, 2025.","DOI":"10.1056\/NEJMra2403308"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77: 1797-1835, 2023.","DOI":"10.1097\/HEP.0000000000000323"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45: 846-854, 2007.","DOI":"10.1002\/hep.21496"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. van Kleef LA, Pustjens J, Schattenberg JM, et al. Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunction. Hepatology 2025.","DOI":"10.1097\/HEP.0000000000001356"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ochoa-Allemant P, Hubbard RA, Kaplan DE, Serper M. Cause-specific mortality in patients with steatotic liver disease in the United States. J Hepatol 83: 860-869, 2025.","DOI":"10.1016\/j.jhep.2025.05.013"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Marti-Aguado D, Calleja JL, Vilar-Gomez E, et al. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease. J Hepatol 81: 930-940, 2024.","DOI":"10.1016\/j.jhep.2024.06.036"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Park H, Lee JY, Park S, et al. Risk Assessment for Carotid Atherosclerosis in Asymptomatic Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Gut Liver 20: 125-136, 2026.","DOI":"10.5009\/gnl250053"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Graupera I, Thiele M, Serra-Burriel M, et al. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population. Clin Gastroenterol Hepatol 20: 2567-2576 e2566, 2022.","DOI":"10.1016\/j.cgh.2021.12.034"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7645-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:37:54Z","timestamp":1781926674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7645-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7645-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7645-26"}}